Molecular and Cellular Biology, volume 25, issue 21, pages 9661-9673

Phosphotyrosine 1062 Is Critical for the In Vivo Activity of the Ret9 Receptor Tyrosine Kinase Isoform

Adrianne Wong 1
Silvia Bogni 2
Pille Kotka 1
Esther de Graaff 2
Vivette D'Agati 3
Frank Costantini 1
Vassilis Pachnis 2
Publication typeJournal Article
Publication date2005-11-01
scimago Q1
SJR1.452
CiteScore9.8
Impact factor3.2
ISSN02707306, 10985549
Molecular Biology
Cell Biology
Abstract
ABSTRACT

The receptor tyrosine kinase Ret plays a critical role in the development of the mammalian excretory and enteric nervous systems. Differential splicing of the primary Ret transcript results in the generation of two main isoforms, Ret9 and Ret51, whose C-terminal amino acid tails diverge after tyrosine (Y) 1062. Monoisoformic mice expressing only Ret9 develop normally and are healthy and fertile. In contrast, animals expressing only Ret51 have aganglionosis of the distal gut and hypoplastic kidneys. By generating monoisoformic mice in which Y1062 of Ret9 has been mutated to phenylalanine, we demonstrate that this amino acid has a critical role in Ret9 signaling that is necessary for the development of the kidneys and the enteric nervous system. These findings argue that the distinct activities of Ret9 and Ret51 result from the differential regulation of Y1062 by C-terminal flanking sequences. However, a mutation which places Y1062 of Ret51 in a Ret9 context improves only marginally the ability of Ret51 to support renal and enteric nervous system development. Finally, monoisoformic mice expressing a variant of Ret9 in which a C-terminal PDZ-binding motif was mutated develop normally and are healthy. Our studies identify Y1062 as a critical regulator of Ret9 signaling and suggest that Ret51-specific motifs are likely to inhibit the activity of this isoform.

Found 
Found 

Top-30

Journals

1
2
3
4
5
Development (Cambridge)
5 publications, 7.04%
Developmental Biology
4 publications, 5.63%
Journal of Clinical Investigation
3 publications, 4.23%
Current Topics in Developmental Biology
3 publications, 4.23%
Scientific Reports
2 publications, 2.82%
Mechanisms of Development
2 publications, 2.82%
Journal of the American Society of Nephrology : JASN
2 publications, 2.82%
Organogenesis
2 publications, 2.82%
Proceedings of the National Academy of Sciences of the United States of America
2 publications, 2.82%
Biology Open
1 publication, 1.41%
Circulation Research
1 publication, 1.41%
International Journal of Molecular Sciences
1 publication, 1.41%
Journal of Developmental Biology
1 publication, 1.41%
Frontiers in Physiology
1 publication, 1.41%
Frontiers in Molecular Neuroscience
1 publication, 1.41%
Nature Reviews Endocrinology
1 publication, 1.41%
Pediatric Surgery International
1 publication, 1.41%
Nature Medicine
1 publication, 1.41%
Pediatric Nephrology
1 publication, 1.41%
Pituitary
1 publication, 1.41%
Nature Clinical Practice Oncology
1 publication, 1.41%
Nature Reviews Cancer
1 publication, 1.41%
Cell and Tissue Research
1 publication, 1.41%
Nature Reviews Neuroscience
1 publication, 1.41%
Seminars in Pediatric Surgery
1 publication, 1.41%
PLoS Genetics
1 publication, 1.41%
American Journal of Human Genetics
1 publication, 1.41%
Endocrinology and Metabolism Clinics of North America
1 publication, 1.41%
Seminars in Nephrology
1 publication, 1.41%
1
2
3
4
5

Publishers

2
4
6
8
10
12
14
16
18
Elsevier
17 publications, 23.94%
Springer Nature
13 publications, 18.31%
The Company of Biologists
6 publications, 8.45%
Wiley
5 publications, 7.04%
American Society for Clinical Investigation
3 publications, 4.23%
Taylor & Francis
3 publications, 4.23%
MDPI
2 publications, 2.82%
Frontiers Media S.A.
2 publications, 2.82%
American Society of Nephrology
2 publications, 2.82%
Proceedings of the National Academy of Sciences (PNAS)
2 publications, 2.82%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 1.41%
Public Library of Science (PLoS)
1 publication, 1.41%
Oxford University Press
1 publication, 1.41%
Cambridge University Press
1 publication, 1.41%
Japan Academy
1 publication, 1.41%
Hindawi Limited
1 publication, 1.41%
American Association for Cancer Research (AACR)
1 publication, 1.41%
American Physiological Society
1 publication, 1.41%
eLife Sciences Publications
1 publication, 1.41%
Annual Reviews
1 publication, 1.41%
Cold Spring Harbor Laboratory
1 publication, 1.41%
IntechOpen
1 publication, 1.41%
2
4
6
8
10
12
14
16
18
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Wong A. et al. Phosphotyrosine 1062 Is Critical for the In Vivo Activity of the Ret9 Receptor Tyrosine Kinase Isoform // Molecular and Cellular Biology. 2005. Vol. 25. No. 21. pp. 9661-9673.
GOST all authors (up to 50) Copy
Wong A., Bogni S., Kotka P., de Graaff E., D'Agati V., Costantini F., Pachnis V. Phosphotyrosine 1062 Is Critical for the In Vivo Activity of the Ret9 Receptor Tyrosine Kinase Isoform // Molecular and Cellular Biology. 2005. Vol. 25. No. 21. pp. 9661-9673.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1128/mcb.25.21.9661-9673.2005
UR - https://doi.org/10.1128/mcb.25.21.9661-9673.2005
TI - Phosphotyrosine 1062 Is Critical for the In Vivo Activity of the Ret9 Receptor Tyrosine Kinase Isoform
T2 - Molecular and Cellular Biology
AU - Wong, Adrianne
AU - Bogni, Silvia
AU - Kotka, Pille
AU - de Graaff, Esther
AU - D'Agati, Vivette
AU - Costantini, Frank
AU - Pachnis, Vassilis
PY - 2005
DA - 2005/11/01
PB - American Society for Microbiology
SP - 9661-9673
IS - 21
VL - 25
PMID - 16227613
SN - 0270-7306
SN - 1098-5549
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2005_Wong,
author = {Adrianne Wong and Silvia Bogni and Pille Kotka and Esther de Graaff and Vivette D'Agati and Frank Costantini and Vassilis Pachnis},
title = {Phosphotyrosine 1062 Is Critical for the In Vivo Activity of the Ret9 Receptor Tyrosine Kinase Isoform},
journal = {Molecular and Cellular Biology},
year = {2005},
volume = {25},
publisher = {American Society for Microbiology},
month = {nov},
url = {https://doi.org/10.1128/mcb.25.21.9661-9673.2005},
number = {21},
pages = {9661--9673},
doi = {10.1128/mcb.25.21.9661-9673.2005}
}
MLA
Cite this
MLA Copy
Wong, Adrianne, et al. “Phosphotyrosine 1062 Is Critical for the In Vivo Activity of the Ret9 Receptor Tyrosine Kinase Isoform.” Molecular and Cellular Biology, vol. 25, no. 21, Nov. 2005, pp. 9661-9673. https://doi.org/10.1128/mcb.25.21.9661-9673.2005.
Found error?